Published: 2 September 2015
Author(s): Rita Banzi, Chiara Gerardi, Vittorio Bertele', Silvio Garattini
Section: Original Article

This paper examines conditional approvals that allow the marketing of medicines with unsettled benefit–risk profiles in the European Union.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.